SCHEMBL6271396

SCHEMBL6271396

C=C(Cn1c(N)nc2nc[nH]c2c1=O)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 7/20 0.50
▸ CCNB1 P14635 7/20 0.50
▸ CCNA2 P20248 7/20 0.50
▸ CDK2 P24941 7/20 0.50
▸ CCNA1 P78396 7/20 0.50
▸ ADORA2A P29274 5/20 0.41
▸ ADORA2B P29275 5/20 0.41
▸ CFTR P13569 2/20 0.40
▸ MGMT P16455 2/20 0.39
▸ PDE4A P27815 5/20 0.38
▸ PDE4B Q07343 5/20 0.38
▸ PDE4C Q08493 5/20 0.38
▸ PDE4D Q08499 5/20 0.38
▸ PDE2A O00408 2/20 0.38
▸ PDE1A P54750 2/20 0.38
▸ PDE1B Q01064 2/20 0.38
▸ PDE1C Q14123 2/20 0.38
▸ PNP P00491 1/20 0.38
▸ PDE5A O76074 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6268093 0.86 ADORA2A (0.42) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL6265538 0.86 MGMT (0.47) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL6266783 0.84 MGMT (0.49) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL6265343 0.82 PDE4A (0.55) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL5504400 0.80 ADORA2A (0.59) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL5048181 0.80 PNP (0.45) CDK2ADORA2AADORA2BMGMTPDE4A
SCHEMBL6271387 0.80 CDK1 (0.37) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL874737 0.78 ADORA2A (0.56) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL28071828 0.78 PNP (0.45) ADORA2AADORA2BMGMTPDE4APDE4B
SCHEMBL6271705 0.78 CDK1 (0.52) CDK1CCNB1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017394-B1 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER REC TECH LTD (GB) 2005-12-07 — — EP disclosed
US-6303618-B1 ADMINISTERING PURINE COMPOUND WHICH INHIBITS CYCLIC DEPENDENT KINASE ACTIVITY FOR THERAPY OF TUMOR OR OTHER CELL PROLIFERATION DISORDER CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2001-10-16 — — US disclosed
WO-1999002162-A9 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER RES CAMPAIGN TECH (GB) 1999-07-29 — — WO disclosed
Send feedback